151
|
Abelev B, Adam J, Adamová D, Aggarwal MM, Rinella GA, Agnello M, Agostinelli A, Agrawal N, Ahammed Z, Ahmad N, Ahmed I, Ahn SU, Ahn SA, Aimo I, Aiola S, Ajaz M, Akindinov A, Alam SN, Aleksandrov D, Alessandro B, Alexandre D, Alici A, Alkin A, Alme J, Alt T, Altinpinar S, Altsybeev I, Alves Garcia Prado C, Andrei C, Andronic A, Anguelov V, Anielski J, Antičić T, Antinori F, Antonioli P, Aphecetche L, Appelshäuser H, Arcelli S, Armesto N, Arnaldi R, Aronsson T, Arsene IC, Arslandok M, Augustinus A, Averbeck R, Awes TC, Azmi MD, Bach M, Badalà A, Baek YW, Bagnasco S, Bailhache R, Bala R, Baldisseri A, Baltasar Dos Santos Pedrosa F, Baral RC, Barbera R, Barile F, Barnaföldi GG, Barnby LS, Barret V, Bartke J, Basile M, Bastid N, Basu S, Bathen B, Batigne G, Batista Camejo A, Batyunya B, Batzing PC, Baumann C, Bearden IG, Beck H, Bedda C, Behera NK, Belikov I, Bellini F, Bellwied R, Belmont-Moreno E, Belmont R, Belyaev V, Bencedi G, Beole S, Berceanu I, Bercuci A, Berdnikov Y, Berenyi D, Berger ME, Bertens RA, Berzano D, Betev L, Bhasin A, Bhat IR, Bhati AK, Bhattacharjee B, Bhom J, Bianchi L, Bianchi N, Bianchin C, Bielčík J, Bielčíková J, Bilandzic A, Bjelogrlic S, Blanco F, Blau D, Blume C, Bock F, Bogdanov A, Bøggild H, Bogolyubsky M, Böhmer FV, Boldizsár L, Bombara M, Book J, Borel H, Borissov A, Bossú F, Botje M, Botta E, Böttger S, Braun-Munzinger P, Bregant M, Breitner T, Broker TA, Browning TA, Broz M, Bruna E, Bruno GE, Budnikov D, Buesching H, Bufalino S, Buncic P, Busch O, Buthelezi Z, Caffarri D, Cai X, Caines H, Calero Diaz L, Caliva A, Calvo Villar E, Camerini P, Carena F, Carena W, Castillo Castellanos J, Casula EAR, Catanescu V, Cavicchioli C, Ceballos Sanchez C, Cepila J, Cerello P, Chang B, Chapeland S, Charvet JL, Chattopadhyay S, Chattopadhyay S, Chelnokov V, Cherney M, Cheshkov C, Cheynis B, Chibante Barroso V, Chinellato DD, Chochula P, Chojnacki M, Choudhury S, Christakoglou P, Christensen CH, Christiansen P, Chujo T, Chung SU, Cicalo C, Cifarelli L, Cindolo F, Cleymans J, Colamaria F, Colella D, Collu A, Colocci M, Conesa Balbastre G, Conesa del Valle Z, Connors ME, Contreras JG, Cormier TM, Corrales Morales Y, Cortese P, Cortés Maldonado I, Cosentino MR, Costa F, Crochet P, Cruz Albino R, Cuautle E, Cunqueiro L, Dainese A, Dang R, Danu A, Das D, Das I, Das K, Das S, Dash A, Dash S, De S, Delagrange H, Deloff A, Dénes E, D’Erasmo G, De Caro A, de Cataldo G, de Cuveland J, De Falco A, De Gruttola D, De Marco N, De Pasquale S, de Rooij R, Diaz Corchero MA, Dietel T, Dillenseger P, Divià R, Di Bari D, Di Liberto S, Di Mauro A, Di Nezza P, Djuvsland Ø, Dobrin A, Dobrowolski T, Domenicis Gimenez D, Dönigus B, Dordic O, Dørheim S, Dubey AK, Dubla A, Ducroux L, Dupieux P, Dutta Majumdar AK, Hilden TE, Ehlers RJ, Elia D, Engel H, Erazmus B, Erdal HA, Eschweiler D, Espagnon B, Esposito M, Estienne M, Esumi S, Evans D, Evdokimov S, Fabris D, Faivre J, Falchieri D, Fantoni A, Fasel M, Fehlker D, Feldkamp L, Felea D, Feliciello A, Feofilov G, Ferencei J, Fernández Téllez A, Ferreiro EG, Ferretti A, Festanti A, Figiel J, Figueredo MAS, Filchagin S, Finogeev D, Fionda FM, Fiore EM, Floratos E, Floris M, Foertsch S, Foka P, Fokin S, Fragiacomo E, Francescon A, Frankenfeld U, Fuchs U, Furget C, Furs A, Fusco Girard M, Gaardhøje JJ, Gagliardi M, Gago AM, Gallio M, Gangadharan DR, Ganoti P, Gao C, Garabatos C, Garcia-Solis E, Gargiulo C, Garishvili I, Gerhard J, Germain M, Gheata A, Gheata M, Ghidini B, Ghosh P, Ghosh SK, Gianotti P, Giubellino P, Gladysz-Dziadus E, Glässel P, Gomez Ramirez A, González-Zamora P, Gorbunov S, Görlich L, Gotovac S, Graczykowski LK, Grelli A, Grigoras A, Grigoras C, Grigoriev V, Grigoryan A, Grigoryan S, Grinyov B, Grion N, Grosse-Oetringhaus JF, Grossiord JY, Grosso R, Guber F, Guernane R, Guerzoni B, Guilbaud M, Gulbrandsen K, Gulkanyan H, Gumbo M, Gunji T, Gupta A, Gupta R, Khan KH, Haake R, Haaland Ø, Hadjidakis C, Haiduc M, Hamagaki H, Hamar G, Hanratty LD, Hansen A, Harris JW, Hartmann H, Harton A, Hatzifotiadou D, Hayashi S, Heckel ST, Heide M, Helstrup H, Herghelegiu A, Herrera Corral G, Hess BA, Hetland KF, Hippolyte B, Hladky J, Hristov P, Huang M, Humanic TJ, Hussain N, Hussain T, Hutter D, Hwang DS, Ilkaev R, Ilkiv I, Inaba M, Innocenti GM, Ionita C, Ippolitov M, Irfan M, Ivanov M, Ivanov V, Jachołkowski A, Jacobs PM, Jahnke C, Jang HJ, Janik MA, Jayarathna PHSY, Jena C, Jena S, Jimenez Bustamante RT, Jones PG, Jung H, Jusko A, Kadyshevskiy V, Kalinak P, Kalweit A, Kamin J, Kang JH, Kaplin V, Kar S, Karasu Uysal A, Karavichev O, Karavicheva T, Karpechev E, Kebschull U, Keidel R, Keijdener DLD, SVN MK, Khan MM, Khan P, Khan SA, Khanzadeev A, Kharlov Y, Kileng B, Kim B, Kim DW, Kim DJ, Kim JS, Kim M, Kim M, Kim S, Kim T, Kirsch S, Kisel I, Kiselev S, Kisiel A, Kiss G, Klay JL, Klein J, Klein-Bösing C, Kluge A, Knichel ML, Knospe AG, Kobdaj C, Kofarago M, Köhler MK, Kollegger T, Kolojvari A, Kondratiev V, Kondratyeva N, Konevskikh A, Kovalenko V, Kowalski M, Kox S, Koyithatta Meethaleveedu G, Kral J, Králik I, Kravčáková A, Krelina M, Kretz M, Krivda M, Krizek F, Kryshen E, Krzewicki M, Kučera V, Kucheriaev Y, Kugathasan T, Kuhn C, Kuijer PG, Kulakov I, Kumar J, Kurashvili P, Kurepin A, Kurepin AB, Kuryakin A, Kushpil S, Kweon MJ, Kwon Y, Ladron de Guevara P, Lagana Fernandes C, Lakomov I, Langoy R, Lara C, Lardeux A, Lattuca A, La Pointe SL, La Rocca P, Lea R, Leardini L, Lee GR, Legrand I, Lehnert J, Lemmon RC, Lenti V, Leogrande E, Leoncino M, León Monzón I, Lévai P, Li S, Lien J, Lietava R, Lindal S, Lindenstruth V, Lippmann C, Lisa MA, Ljunggren HM, Lodato DF, Loenne PI, Loggins VR, Loginov V, Lohner D, Loizides C, Lopez X, López Torres E, Lu XG, Luettig P, Lunardon M, Luparello G, Ma R, Maevskaya A, Mager M, Mahapatra DP, Mahmood SM, Maire A, Majka RD, Malaev M, Maldonado Cervantes I, Malinina L, Mal’Kevich D, Malzacher P, Mamonov A, Manceau L, Manko V, Manso F, Manzari V, Marchisone M, Mareš J, Margagliotti GV, Margotti A, Marín A, Markert C, Marquard M, Martashvili I, Martin NA, Martinengo P, Martínez MI, Martínez García G, Martin Blanco J, Martynov Y, Mas A, Masciocchi S, Masera M, Masoni A, Massacrier L, Mastroserio A, Matyja A, Mayer C, Mazer J, Mazzoni MA, Meddi F, Menchaca-Rocha A, Meninno E, Mercado Pérez J, Meres M, Miake Y, Mikhaylov K, Milano L, Milosevic J, Mischke A, Mishra AN, Miśkowiec D, Mitra J, Mitu CM, Mlynarz J, Mohammadi N, Mohanty B, Molnar L, Montaño Zetina L, Montes E, Morando M, Moreira De Godoy DA, Moretto S, Morreale A, Morsch A, Muccifora V, Mudnic E, Mühlheim D, Muhuri S, Mukherjee M, Müller H, Munhoz MG, Murray S, Musa L, Musinsky J, Nandi BK, Nania R, Nappi E, Nattrass C, Nayak K, Nayak TK, Nazarenko S, Nedosekin A, Nicassio M, Niculescu M, Niedziela J, Nielsen BS, Nikolaev S, Nikulin S, Nikulin V, Nilsen BS, Noferini F, Nomokonov P, Nooren G, Norman J, Nyanin A, Nystrand J, Oeschler H, Oh S, Oh SK, Okatan A, Okubo T, Olah L, Oleniacz J, Oliveira Da Silva AC, Onderwaater J, Oppedisano C, Ortiz Velasquez A, Oskarsson A, Otwinowski J, Oyama K, Ozdemir M, Sahoo P, Pachmayer Y, Pachr M, Pagano P, Paić G, Pajares C, Pal SK, Palmeri A, Pant D, Papikyan V, Pappalardo GS, Pareek P, Park WJ, Parmar S, Passfeld A, Patalakha DI, Paticchio V, Paul B, Pawlak T, Peitzmann T, Pereira Da Costa H, Pereira De Oliveira Filho E, Peresunko D, Pérez Lara CE, Pesci A, Peskov V, Pestov Y, Petráček V, Petran M, Petris M, Petrovici M, Petta C, Piano S, Pikna M, Pillot P, Pinazza O, Pinsky L, Piyarathna DB, Płoskoń M, Planinic M, Pluta J, Pochybova S, Podesta-Lerma PLM, Poghosyan MG, Pohjoisaho EHO, Polichtchouk B, Poljak N, Pop A, Porteboeuf-Houssais S, Porter J, Potukuchi B, Prasad SK, Preghenella R, Prino F, Pruneau CA, Pshenichnov I, Puccio M, Puddu G, Pujahari P, Punin V, Putschke J, Qvigstad H, Rachevski A, Raha S, Rajput S, Rak J, Rakotozafindrabe A, Ramello L, Raniwala R, Raniwala S, Räsänen SS, Rascanu BT, Rathee D, Rauf AW, Razazi V, Read KF, Real JS, Redlich K, Reed RJ, Rehman A, Reichelt P, Reicher M, Reidt F, Renfordt R, Reolon AR, Reshetin A, Rettig F, Revol JP, Reygers K, Riabov V, Ricci RA, Richert T, Richter M, Riedler P, Riegler W, Riggi F, Rivetti A, Rocco E, Rodríguez Cahuantzi M, Rodriguez Manso A, Røed K, Rogochaya E, Rohni S, Rohr D, Röhrich D, Romita R, Ronchetti F, Ronflette L, Rosnet P, Rossi A, Roukoutakis F, Roy A, Roy C, Roy P, Rubio Montero AJ, Rui R, Russo R, Ryabinkin E, Ryabov Y, Rybicki A, Sadovsky S, Šafařík K, Sahlmuller B, Sahoo R, Sahu PK, Saini J, Sakai S, Salgado CA, Salzwedel J, Sambyal S, Samsonov V, Sanchez Castro X, Sánchez Rodríguez FJ, Šándor L, Sandoval A, Sano M, Santagati G, Sarkar D, Scapparone E, Scarlassara F, Scharenberg RP, Schiaua C, Schicker R, Schmidt C, Schmidt HR, Schuchmann S, Schukraft J, Schulc M, Schuster T, Schutz Y, Schwarz K, Schweda K, Scioli G, Scomparin E, Scott R, Segato G, Seger JE, Sekiguchi Y, Selyuzhenkov I, Senosi K, Seo J, Serradilla E, Sevcenco A, Shabetai A, Shabratova G, Shahoyan R, Shangaraev A, Sharma A, Sharma N, Sharma S, Shigaki K, Shtejer K, Sibiriak Y, Siddhanta S, Siemiarczuk T, Silvermyr D, Silvestre C, Simatovic G, Singaraju R, Singh R, Singha S, Singhal V, Sinha BC, Sinha T, Sitar B, Sitta M, Skaali TB, Skjerdal K, Slupecki M, Smirnov N, Snellings RJM, Søgaard C, Soltz R, Song J, Song M, Soramel F, Sorensen S, Spacek M, Spiriti E, Sputowska I, Spyropoulou-Stassinaki M, Srivastava BK, Stachel J, Stan I, Stefanek G, Steinpreis M, Stenlund E, Steyn G, Stiller JH, Stocco D, Stolpovskiy M, Strmen P, Suaide AAP, Sugitate T, Suire C, Suleymanov M, Sultanov R, Šumbera M, Symons TJM, Szabo A, Szanto de Toledo A, Szarka I, Szczepankiewicz A, Szymanski M, Takahashi J, Tangaro MA, Tapia Takaki JD, Tarantola Peloni A, Tarazona Martinez A, Tariq M, Tarzila MG, Tauro A, Tejeda Muñoz G, Telesca A, Terasaki K, Terrevoli C, Thäder J, Thomas D, Tieulent R, Timmins AR, Toia A, Trubnikov V, Trzaska WH, Tsuji T, Tumkin A, Turrisi R, Tveter TS, Ullaland K, Uras A, Usai GL, Vajzer M, Vala M, Valencia Palomo L, Vallero S, Vande Vyvre P, Van Der Maarel J, Van Hoorne JW, van Leeuwen M, Vargas A, Vargyas M, Varma R, Vasileiou M, Vasiliev A, Vechernin V, Veldhoen M, Velure A, Venaruzzo M, Vercellin E, Vergara Limón S, Vernet R, Verweij M, Vickovic L, Viesti G, Viinikainen J, Vilakazi Z, Villalobos Baillie O, Vinogradov A, Vinogradov L, Vinogradov Y, Virgili T, Vislavicius V, Viyogi YP, Vodopyanov A, Völkl MA, Voloshin K, Voloshin SA, Volpe G, von Haller B, Vorobyev I, Vranic D, Vrláková J, Vulpescu B, Vyushin A, Wagner B, Wagner J, Wagner V, Wang M, Wang Y, Watanabe D, Weber M, Weber SG, Wessels JP, Westerhoff U, Wiechula J, Wikne J, Wilde M, Wilk G, Wilkinson J, Williams MCS, Windelband B, Winn M, Yaldo CG, Yamaguchi Y, Yang H, Yang P, Yang S, Yano S, Yasnopolskiy S, Yi J, Yin Z, Yoo IK, Yushmanov I, Zaccolo V, Zach C, Zaman A, Zampolli C, Zaporozhets S, Zarochentsev A, Závada P, Zaviyalov N, Zbroszczyk H, Zgura IS, Zhalov M, Zhang H, Zhang X, Zhang Y, Zhao C, Zhigareva N, Zhou D, Zhou F, Zhou Y, Zhuo Z, Zhu H, Zhu J, Zhu X, Zichichi A, Zimmermann A, Zimmermann MB, Zinovjev G, Zoccarato Y, Zyzak M. Production of [Formula: see text] and [Formula: see text] in proton-proton collisions at [Formula: see text] 7 TeV. THE EUROPEAN PHYSICAL JOURNAL. C, PARTICLES AND FIELDS 2015; 75:1. [PMID: 25983644 PMCID: PMC4424041 DOI: 10.1140/epjc/s10052-014-3191-x] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 06/13/2014] [Accepted: 11/23/2014] [Indexed: 06/04/2023]
Abstract
The production of the strange and double-strange baryon resonances ([Formula: see text], [Formula: see text]) has been measured at mid-rapidity ([Formula: see text][Formula: see text]) in proton-proton collisions at [Formula: see text] [Formula: see text] 7 TeV with the ALICE detector at the LHC. Transverse momentum spectra for inelastic collisions are compared to QCD-inspired models, which in general underpredict the data. A search for the [Formula: see text] pentaquark, decaying in the [Formula: see text] channel, has been carried out but no evidence is seen.
Collapse
|
research-article |
10 |
19 |
152
|
Brodie MJ, Boobis AR, Toverud EL, Ellis W, Murray S, Dollery CT, Webster S, Harrison R. Drug metabolism in white vegetarians. Br J Clin Pharmacol 1980; 9:523-5. [PMID: 7397068 PMCID: PMC1429941 DOI: 10.1111/j.1365-2125.1980.tb05853.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023] Open
|
research-article |
45 |
19 |
153
|
Murray S, Watson D, Davies DS. Bistrifluoromethylaryl derivatives for drug analysis by gas chromatography electron capture negative ion chemical ionization mass spectrometry. Application to the measurement of (N-dicyclopropylmethyl)amino-2-oxazoline in plasma. BIOMEDICAL MASS SPECTROMETRY 1985; 12:230-7. [PMID: 2862929 DOI: 10.1002/bms.1200120509] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
A gas chromatographic mass spectrometric assay for (N-dicyclopropylmethyl) amino-2-oxazoline in plasma with a detection limit of 0.1 ng ml-1 was required. Various fluoroaryl derivatives of this compound (code name S3341) were synthesized and their positive ion chemical ionization and electron capture negative ion chemical ionization mass spectra recorded. While fluorobenzyl derivatives of S3341 could be made by heating with the requisite benzyl bromide and diisopropylethylamine in acetonitrile, initial efforts to synthesize corresponding fluorobenzoyl derivatives using a benzoyl chloride in dry ethyl acetate at 60 degrees C were unsuccessful. Mass spectral data indicated that only a fragment of the oxazoline ring was retained in the reaction product and that an N-(2-chloroethyl)benzamide was formed. However, when diisopropylethylamine was included in the reaction mixture, a benzoyl derivative of the complete molecule was obtained. The mechanisms of these reactions are discussed. The negative ion mass spectrum of the 3,5-bistrifluoromethylbenzoyl derivative of S3341 has a base peak at m/z 420 (the molecular ion) and, when this ion is specifically monitored, an amount of derivative equivalent to 1 pg of S3341 can be detected. This allowed the development of an assay for S3341 in plasma with a precision of 9% (SD) at 0.2 ng ml-1 and a lower limit for quantitative determination of 0.1 ng ml-1.
Collapse
|
|
40 |
19 |
154
|
Chou YK, Bourdette DN, Barnes D, Finn TP, Murray S, Unsicker L, Robey I, Whitham RH, Buenafe AC, Allegretta M, Offner H, Vandenbark AA. IL-7 enhances Ag-specific human T cell response by increasing expression of IL-2R alpha and gamma chains. J Neuroimmunol 1999; 96:101-11. [PMID: 10227429 DOI: 10.1016/s0165-5728(99)00002-8] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
Interleukin-7 has demonstrated potent enhancing effects on the growth and differentiation of several immature cell types, including thymocytes, and on survival of resting and antigen activated T cells. In this study, we evaluated the effects of IL-7 on post-thymic antigen-specific T cells from human blood. IL-7 was found to enhance proliferation responses and IFN-gamma secretion of myelin or recall Ag-specific Th1 cells through the selective up-regulation of the IL-2Ralpha and gamma but not beta chains in both an Ag-dependent and Ag-independent manner, but did not affect monocytes, B cells, or NK cells. These functions of IL-7 enhanced the detection of Th1 but not Th2 cell frequency by >2.5 fold, and promoted selection of Ag-specific Th1 cells by the limiting dilution method. Moreover, IL-7 pretreatment conferred increased resistance of CD4+ T cells to CD8+ cell lysis. These studies demonstrate that IL-7 promotes the growth and survival of circulating Ag-specific human Th1 cells through a mechanism that probably involves the gammac common receptor for IL-2 family members that includes IL-7.
Collapse
|
|
26 |
18 |
155
|
Murray S, Waddell KA. The electron capture negative ion chemical ionization mass spectra of 2-(4′,6′-bistrifluoromethyl-2′-pyrimidinyl)-tetrahydroisoquinoline and 4-substituted analogues. ACTA ACUST UNITED AC 1982. [DOI: 10.1002/bms.1200091103] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
|
43 |
18 |
156
|
Tan OT, Stafford TJ, Murray S, Kurban AK. Histologic comparison of the pulsed dye laser and copper vapor laser effects on pig skin. Lasers Surg Med 1990; 10:551-8. [PMID: 2263154 DOI: 10.1002/lsm.1900100607] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Albino pig skin was exposed to the copper vapor (CVL) and flash-lamp pulsed dye (PDL) lasers at 578 nm with a 3 mm diameter spotsize over a range of fluences until purpura and whitening were first established. The total irradiation time was the parameter that was varied in order for the CVL to reach the desired fluence. The lowest fluence producing each clinical endpoint was designated the threshold fluence: 34 J/cm2 was required to produce purpura using the CVL compared to 7.5 J/cm2 with the PDL laser. Histologically, skin exposed to purpura fluences from the CVL revealed the presence of constricted, disrupted papillary dermal blood vessels with trapped RBC's within them which were unlike those exposed to PDL where the irradiated vessels were dilated and packed with masses of intravascular agglutinated RBC's. The whitening threshold fluences for the CVL and PDL lasers were 67 J/cm2 and 29 J/cm2, respectively. Streaming of epidermal cells and dermal collagen denaturation were observed in CVL irradiated skin, compared to occasional dyskeratotic epidermal cells and focal dermal collagen denaturation following PDL exposure. The mechanisms responsible for the clinical and histologic changes produced by the two laser systems are discussed.
Collapse
|
Comparative Study |
35 |
18 |
157
|
|
|
48 |
18 |
158
|
Marini G, Murray S, Goldhirsch A, Gelber RD, Castiglione-Gertsch M, Price KN, Tattersall MH, Rudenstam CM, Collins J, Lindtner J, Cavalli F, Cortés-Funes H, Gudgeon A, Forbes JF, Galligioni E, Coates AS, Senn HJ. The effect of adjuvant prednisone combined with CMF on patterns of relapse and occurrence of second malignancies in patients with breast cancer. International (Ludwig) Breast Cancer Study Group. Ann Oncol 1996; 7:245-50. [PMID: 8740787 DOI: 10.1093/oxfordjournals.annonc.a010567] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
Abstract
BACKGROUND The addition of low-dose prednisone (p) to the adjuvant regimen of cyclophosphamide, methotrexate, 5-fluorouracil (CMF) allowed patients to receive a larger dose of cytotoxics when compared with those on CMF alone. However, disease-free survival and overall survival were similar for the two groups. To test the hypothesis that low-dose prednisone might influence the efficacy of the cytotoxic regimen used, the toxicity profiles of the two treatment regimens and the patterns of treatment failure (relapse, second malignancy, or death) were examined. PATIENTS AND METHODS 491 premenopausal and perimenopausal patients with one to three positive axillary lymph nodes included in International (Ludwig) Breast Cancer Study Group (IBCSG) trial I from 1978 to 1981 and randomized to receive CMF or CMFp were analyzed for differences in long-term outcome and toxic events. The 250 patients assigned to CMF and prednisone received on the average 12% more cytotoxic drugs than those who received CMF alone. RESULTS The 13-year DFS for the CMFp group was 49% as compared to 52% for CMF alone, and the respective OS percents were 59% and 65%. Several toxic effects such as leukopenia, alopecia, mucositis and induced amenorrhea were reported at a similar incidence in the two treatment groups. Using cumulative incidence methodology for competing risks, we detected a statistically significant increase in first relapse in the skeleton for the CMFp group at 13 years follow-up with a relative risk (RR) of 2.06 [95% confidence interval (CI), 1.23 to 3.46; P = 0.004]. Patients with larger tumors in the CMFp regimen were especially subject to this increase with a RR for failure in the skeleton of 3.32 (95% CI, 1.57 to 7.02; P = 0.0005). CMFp-treated patients also had a larger proportion of second malignancies (not breast cancer), with RR of 3.34 (95% CI, 0.91 to 12.31; P = 0.09). CONCLUSIONS Low-dose continuous prednisone added to adjuvant CMF chemotherapy enabled the use of higher doses of cytotoxics. This increased dose had no beneficial effect on treatment outcome, but was associated with an increased risk for bone relapses and a small, not statistically significant increased incidence of second malignancies. The effects of steroids, which are widely used as antiemetics (oral or pulse injection) together with cytotoxics, should be investigated to identify their influence upon treatment outcome.
Collapse
|
Clinical Trial |
29 |
18 |
159
|
Turley AJ, Murray S, Thambyrajah J. Pre-excited atrial fibrillation triggered by intravenous adenosine: a commonly used drug with potentially life-threatening adverse effects. Emerg Med J 2008; 25:46-8. [PMID: 18156545 DOI: 10.1136/emj.2007.051227] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Although serious adverse events following adenosine administration are rare, it should only be administered in an environment where continuous ECG monitoring and emergency resuscitation equipment are available. The case report describes the development of pre-excited atrial fibrillation in a 31-year-old woman with Wolff-Parkinson-White syndrome following the administration of adenosine. She had previously been fit and well and was admitted to the coronary care unit with a 2 h history of regular palpitations. A 12-lead ECG showed a narrow QRS complex tachycardia. Carotid sinus massage was unsuccessful in terminating the tachycardia and the patient subsequently received rapid boluses of intravenous adenosine. The cardiac rhythm degenerated into atrial fibrillation with ventricular pre-excitation following 12 mg adenosine.
Collapse
|
Journal Article |
17 |
17 |
160
|
Murray S, Cole B. Variance and sample size calculations in quality-of-life--adjusted survival analysis (Q-TWiST). Biometrics 2000; 56:173-82. [PMID: 10783793 DOI: 10.1111/j.0006-341x.2000.00173.x] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The Quality-Adjusted Time Without Symptoms or Toxicity (Q-TWiST) statistic previously introduced by Glasziou, Simes and Gelber (1990, Statistics in Medicine 9, 1259-1276) combines toxicity, disease-free survival, and overall survival information in assessing the impact of treatments on the lives of patients. This methodology has received positive reviews from clinicians as intuitive and useful, but to date, the variance of this statistic has remained unspecified. We review aspects of the Q-TWiST method for analyzing clinical trial data, extend the method to accommodate multiple treatment arms, and provide closed-form asymptotic variance formulas. We also provide a framework for designing Q-TWiST clinical trials with sample sizes determined using the derived asymptotic variance formulas. Trials currently collecting quality of life data did not have the benefit of these sample size calculation techniques in designing their studies.
Collapse
|
|
25 |
17 |
161
|
Murray S, Waddell KA, Davies DS. The measurement of clonidine in human plasma and urine by combined gas chromatography mass spectrometry with ammonia chemical ionization. BIOMEDICAL MASS SPECTROMETRY 1981; 8:500-2. [PMID: 7295874 DOI: 10.1002/bms.1200081007] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Abstract
The dimethyl derivatives of clonidine and [2H4]clonidine give good chemical ionization mass spectra when ammonia is used as reagent gas. A gas chromatographic mass spectrometric selected ion monitoring assay for the estimation of clonidine in plasma and urine using ammonia chemical ionization is described.
Collapse
|
|
44 |
17 |
162
|
Howard-Jones PA, Murray S. Ideational Productivity, Focus of Attention, and Context. CREATIVITY RESEARCH JOURNAL 2003. [DOI: 10.1207/s15326934crj152&3_07] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
|
22 |
17 |
163
|
Murray S, Hickey JB, Houang E. Significant bacteremia associated with replacement of intrauterine contraceptive device. Am J Obstet Gynecol 1987; 156:698-700. [PMID: 3826221 DOI: 10.1016/0002-9378(87)90081-0] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
Blood culture samples were taken from 23 women at different stages when an intrauterine contraceptive device was replaced. Transient bacteremia resulting from vaginal organisms was found in 13% of women 4 to 6 minutes after insertion of the new device. Previous reports have failed to demonstrate bacteremia associated with either first insertion or removal of intrauterine contraceptive device. Our results show that replacement of an intrauterine contraceptive device, a more traumatic procedure, causes significant bacteremia, and chemoprophylaxis should be given to patients in the groups at risk.
Collapse
|
|
38 |
16 |
164
|
Lynch AM, Murray S, Gooderham NJ, Boobis AR. Exposure to and activation of dietary heterocyclic amines in humans. Crit Rev Oncol Hematol 1995; 21:19-31. [PMID: 8822495 DOI: 10.1016/1040-8428(95)00178-6] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
|
Review |
30 |
16 |
165
|
Allport JR, Donnelly LE, Hayes BP, Murray S, Rendell NB, Ray KP, MacDermot J. Reduction by inhibitors of mono(ADP-ribosyl)transferase of chemotaxis in human neutrophil leucocytes by inhibition of the assembly of filamentous actin. Br J Pharmacol 1996; 118:1111-8. [PMID: 8818333 PMCID: PMC1909602 DOI: 10.1111/j.1476-5381.1996.tb15513.x] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
1. Chemotaxis of human neutrophils is mediated by numerous agents [e.g. N-formyl-methionyl-leucyl-phenylalanine (FMLP) and platelet activating factor (PAF)] whose receptors are coupled to phospholipase C. However, the subsequent transduction pathway mediating cell movement remains obscure. We now propose involvement of mono(ADP-ribosyl)transferase activity in receptor-dependent chemotaxis. 2. Human neutrophils were isolated from whole blood and measurements were made of FMLP or PAF-dependent actin polymerization and chemotaxis. The activity of cell surface Arg-specific mono(ADP-ribosyl)transferase was also measured. Each of these activities was inhibited by vitamin K3 and similar IC50 values obtained (4.67 +/- 1.46 microM, 2.0 +/- 0.1 microM and 4.7 +/- 0.1 microM respectively). 3. There were similar close correlations between inhibition of (a) enzyme activity and (b) actin polymerization or chemotaxis by other known inhibitors of mono(ADP-ribosyl)transferase, namely vitamin K1, novobiocin, nicotinamide and the efficient pseudosubstrate, diethylamino(benzylidineamino)guanidine (DEA-BAG). 4. Intracellular Ca2+ was measured by laser scanning confocal microscopy with two fluorescent dyes (Fluo-3 and Fura-Red). Exposure of human neutrophils to FMLP or PAF was followed by transient increases in intracellular Ca2+ concentration, but the inhibitors of mono(ADP-ribosyl)transferase listed above had no effect on the magnitude of the response. 5. A panel of selective inhibitors of protein kinase C, tyrosine kinase, protein kinases A and G or phosphatases 1 and 2A showed no consistent inhibition of FMLP-dependent polymerization of actin. 6. We conclude that eukaryotic Arg-specific mono(ADP-ribosyl)transferase activity may be implicated in the transduction pathway mediating chemotaxis of human neutrophils, with involvement in the assembly of actin-containing cytoskeletal microfilaments.
Collapse
|
research-article |
29 |
16 |
166
|
Murray S, Bashir K, Lees KR, Muir K, MacAlpine C, Roberts M, Langhorne P. Epidemiological Aspects of Referral to TIA Clinics in Glasgow. Scott Med J 2016; 52:4-8. [PMID: 17373416 DOI: 10.1258/rsmsmj.52.1.4] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
A retrospective cohort study was carried out of new referrals to transient ischaemic attack (TIA) clinics in Glasgow. The aims of the study were to describe the profile of referrals and to assess the odds ratios for TIA, minor stroke or amaurosis fugax of both cardiovascular risk factors and clinical features. In total, data were collected for 813 new referrals in a period of six months. Thirteen point eight percent of referrals were from other Health Boards. The overall referral rate among residents of Greater Glasgow NHS Board was 165.6 per 100,000 per year. About 20% of referrals were made by clinicians in secondary care. The specialties from which referrals were most commonly made were accident and emergency, general medicine, ophthalmology and geriatric assessment. The most common risk factors in patients referred were hypertension (52.9%), smoking (31.7%), ischaemic heart disease (22.7%) and former smokers (22.4%). The most common clinical features were hemiparesis (13.3%), weakness of an upper limb (8.7%), vertigo (7.9%) and dysphasia (7.3%). In 48.7% of cases, a non-cerebrovascular diagnosis was made. Separate multivariate models were established for risk factors and clinical features. In the model for risk factors, five factors were significant for risk of TIA, stroke or amaurosis fugax. These were hyperlipidaemia, age over 64 years, hypertension, smoking and ex-smoking. In the model for clinical features, five factors were also significant. These were visual field defect, speech defact, facial weakness and hemiparesis.
Collapse
|
|
9 |
16 |
167
|
Allen TD, Rutherford SA, Murray S, Sanderson HS, Gardiner F, Kiseleva E, Goldberg MW, Drummond SP. A protocol for isolating Xenopus oocyte nuclear envelope for visualization and characterization by scanning electron microscopy (SEM) or transmission electron microscopy (TEM). Nat Protoc 2008; 2:1166-72. [PMID: 17546011 DOI: 10.1038/nprot.2007.137] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
This protocol details methods for the isolation of oocyte nuclear envelopes (NEs) from the African clawed toad Xenopus laevis, immunogold labeling of component proteins and subsequent visualization by field-emission scanning electron microscopy (FESEM) and transmission electron microscopy (TEM). This procedure involves the initial removal of the ovaries from mature female X. laevis, the dissection of individual oocytes, then the manual isolation of the giant nucleus and subsequent preparation for high-resolution visualization. Unlike light microscopy, and its derivative technologies, electron microscopy enables 3-5 nm resolution of nuclear structures, thereby giving unrivalled opportunities for investigation and immunological characterization in situ of nuclear structures and their structural associations. There are a number of stages where samples can be stored, although we recommend that this protocol take no longer than 2 d. Samples processed for FESEM can be stored for weeks under vacuum, allowing considerable time for image acquisition.
Collapse
|
Research Support, Non-U.S. Gov't |
17 |
16 |
168
|
Abelev B, Adam J, Adamová D, Aggarwal MM, Aglieri Rinella G, Agnello M, Agostinelli A, Agrawal N, Ahammed Z, Ahmad N, Ahmed I, Ahn SU, Ahn SA, Aimo I, Aiola S, Ajaz M, Akindinov A, Alam SN, Aleksandrov D, Alessandro B, Alexandre D, Alici A, Alkin A, Alme J, Alt T, Altinpinar S, Altsybeev I, Alves Garcia Prado C, Andrei C, Andronic A, Anguelov V, Anielski J, Antičić T, Antinori F, Antonioli P, Aphecetche L, Appelshäuser H, Arcelli S, Armesto N, Arnaldi R, Aronsson T, Arsene IC, Arslandok M, Augustinus A, Averbeck R, Awes TC, Azmi MD, Bach M, Badalà A, Baek YW, Bagnasco S, Bailhache R, Bala R, Baldisseri A, Baltasar Dos Santos Pedrosa F, Baral RC, Barbera R, Barile F, Barnaföldi GG, Barnby LS, Barret V, Bartke J, Basile M, Bastid N, Basu S, Bathen B, Batigne G, Batista Camejo A, Batyunya B, Batzing PC, Baumann C, Bearden IG, Beck H, Bedda C, Behera NK, Belikov I, Bellini F, Bellwied R, Belmont-Moreno E, Belmont R, Belyaev V, Bencedi G, Beole S, Berceanu I, Bercuci A, Berdnikov Y, Berenyi D, Berger ME, Bertens RA, Berzano D, Betev L, Bhasin A, Bhat IR, Bhati AK, Bhattacharjee B, Bhom J, Bianchi L, Bianchi N, Bianchin C, Bielčík J, Bielčíková J, Bilandzic A, Bjelogrlic S, Blanco F, Blau D, Blume C, Bock F, Bogdanov A, Bøggild H, Bogolyubsky M, Böhmer FV, Boldizsár L, Bombara M, Book J, Borel H, Borissov A, Bossú F, Botje M, Botta E, Böttger S, Braun-Munzinger P, Bregant M, Breitner T, Broker TA, Browning TA, Broz M, Bruna E, Bruno GE, Budnikov D, Buesching H, Bufalino S, Buncic P, Busch O, Buthelezi Z, Caffarri D, Cai X, Caines H, Calero Diaz L, Caliva A, Calvo Villar E, Camerini P, Carena F, Carena W, Castillo Castellanos J, Casula EAR, Catanescu V, Cavicchioli C, Ceballos Sanchez C, Cepila J, Cerello P, Chang B, Chapeland S, Charvet JL, Chattopadhyay S, Chattopadhyay S, Chelnokov V, Cherney M, Cheshkov C, Cheynis B, Chibante Barroso V, Chinellato DD, Chochula P, Chojnacki M, Choudhury S, Christakoglou P, Christensen CH, Christiansen P, Chujo T, Chung SU, Cicalo C, Cifarelli L, Cindolo F, Cleymans J, Colamaria F, Colella D, Collu A, Colocci M, Conesa Balbastre G, Conesa Del Valle Z, Connors ME, Contreras JG, Cormier TM, Corrales Morales Y, Cortese P, Cortés Maldonado I, Cosentino MR, Costa F, Crochet P, Cruz Albino R, Cuautle E, Cunqueiro L, Dainese A, Dang R, Danu A, Das D, Das I, Das K, Das S, Dash A, Dash S, De S, Delagrange H, Deloff A, Dénes E, D'Erasmo G, De Caro A, de Cataldo G, de Cuveland J, De Falco A, De Gruttola D, De Marco N, De Pasquale S, de Rooij R, Diaz Corchero MA, Dietel T, Dillenseger P, Divià R, Di Bari D, Di Liberto S, Di Mauro A, Di Nezza P, Djuvsland Ø, Dobrin A, Dobrowolski T, Domenicis Gimenez D, Dönigus B, Dordic O, Dørheim S, Dubey AK, Dubla A, Ducroux L, Dupieux P, Dutta Majumdar AK, Hilden TE, Ehlers RJ, Elia D, Engel H, Erazmus B, Erdal HA, Eschweiler D, Espagnon B, Esposito M, Estienne M, Esumi S, Evans D, Evdokimov S, Fabris D, Faivre J, Falchieri D, Fantoni A, Fasel M, Fehlker D, Feldkamp L, Felea D, Feliciello A, Feofilov G, Ferencei J, Fernández Téllez A, Ferreiro EG, Ferretti A, Festanti A, Figiel J, Figueredo MAS, Filchagin S, Finogeev D, Fionda FM, Fiore EM, Floratos E, Floris M, Foertsch S, Foka P, Fokin S, Fragiacomo E, Francescon A, Frankenfeld U, Fuchs U, Furget C, Furs A, Fusco Girard M, Gaardhøje JJ, Gagliardi M, Gago AM, Gallio M, Gangadharan DR, Ganoti P, Gao C, Garabatos C, Garcia-Solis E, Gargiulo C, Garishvili I, Gerhard J, Germain M, Gheata A, Gheata M, Ghidini B, Ghosh P, Ghosh SK, Gianotti P, Giubellino P, Gladysz-Dziadus E, Glässel P, Gomez Ramirez A, González-Zamora P, Gorbunov S, Görlich L, Gotovac S, Graczykowski LK, Grelli A, Grigoras A, Grigoras C, Grigoriev V, Grigoryan A, Grigoryan S, Grinyov B, Grion N, Grosse-Oetringhaus JF, Grossiord JY, Grosso R, Guber F, Guernane R, Guerzoni B, Guilbaud M, Gulbrandsen K, Gulkanyan H, Gumbo M, Gunji T, Gupta A, Gupta R, Khan KH, Haake R, Haaland Ø, Hadjidakis C, Haiduc M, Hamagaki H, Hamar G, Hanratty LD, Hansen A, Harris JW, Hartmann H, Harton A, Hatzifotiadou D, Hayashi S, Heckel ST, Heide M, Helstrup H, Herghelegiu A, Herrera Corral G, Hess BA, Hetland KF, Hippolyte B, Hladky J, Hristov P, Huang M, Humanic TJ, Hussain N, Hutter D, Hwang DS, Ilkaev R, Ilkiv I, Inaba M, Innocenti GM, Ionita C, Ippolitov M, Irfan M, Ivanov M, Ivanov V, Jachołkowski A, Jacobs PM, Jahnke C, Jang HJ, Janik MA, Jayarathna PHSY, Jena C, Jena S, Jimenez Bustamante RT, Jones PG, Jung H, Jusko A, Kadyshevskiy V, Kalcher S, Kalinak P, Kalweit A, Kamin J, Kang JH, Kaplin V, Kar S, Karasu Uysal A, Karavichev O, Karavicheva T, Karpechev E, Kebschull U, Keidel R, Keijdener DLD, Keil Svn M, Khan MM, Khan P, Khan SA, Khanzadeev A, Kharlov Y, Kileng B, Kim B, Kim DW, Kim DJ, Kim JS, Kim M, Kim M, Kim S, Kim T, Kirsch S, Kisel I, Kiselev S, Kisiel A, Kiss G, Klay JL, Klein J, Klein-Bösing C, Kluge A, Knichel ML, Knospe AG, Kobdaj C, Kofarago M, Köhler MK, Kollegger T, Kolojvari A, Kondratiev V, Kondratyeva N, Konevskikh A, Kovalenko V, Kowalski M, Kox S, Koyithatta Meethaleveedu G, Kral J, Králik I, Kravčáková A, Krelina M, Kretz M, Krivda M, Krizek F, Kryshen E, Krzewicki M, Kučera V, Kucheriaev Y, Kugathasan T, Kuhn C, Kuijer PG, Kulakov I, Kumar J, Kurashvili P, Kurepin A, Kurepin AB, Kuryakin A, Kushpil S, Kweon MJ, Kwon Y, Ladron de Guevara P, Lagana Fernandes C, Lakomov I, Langoy R, Lara C, Lardeux A, Lattuca A, La Pointe SL, La Rocca P, Lea R, Leardini L, Lee GR, Legrand I, Lehnert J, Lemmon RC, Lenti V, Leogrande E, Leoncino M, León Monzón I, Lévai P, Li S, Lien J, Lietava R, Lindal S, Lindenstruth V, Lippmann C, Lisa MA, Ljunggren HM, Lodato DF, Loenne PI, Loggins VR, Loginov V, Lohner D, Loizides C, Lopez X, López Torres E, Lu XG, Luettig P, Lunardon M, Luparello G, Ma R, Maevskaya A, Mager M, Mahapatra DP, Mahmood SM, Maire A, Majka RD, Malaev M, Maldonado Cervantes I, Malinina L, Mal'Kevich D, Malzacher P, Mamonov A, Manceau L, Manko V, Manso F, Manzari V, Marchisone M, Mareš J, Margagliotti GV, Margotti A, Marín A, Markert C, Marquard M, Martashvili I, Martin NA, Martinengo P, Martínez MI, Martínez García G, Martin Blanco J, Martynov Y, Mas A, Masciocchi S, Masera M, Masoni A, Massacrier L, Mastroserio A, Matyja A, Mayer C, Mazer J, Mazzoni MA, Meddi F, Menchaca-Rocha A, Meninno E, Mercado Pérez J, Meres M, Miake Y, Mikhaylov K, Milano L, Milosevic J, Mischke A, Mishra AN, Miśkowiec D, Mitra J, Mitu CM, Mlynarz J, Mohammadi N, Mohanty B, Molnar L, Montaño Zetina L, Montes E, Morando M, Moreira De Godoy DA, Moretto S, Morreale A, Morsch A, Muccifora V, Mudnic E, Mühlheim D, Muhuri S, Mukherjee M, Müller H, Munhoz MG, Murray S, Musa L, Musinsky J, Nandi BK, Nania R, Nappi E, Nattrass C, Nayak K, Nayak TK, Nazarenko S, Nedosekin A, Nicassio M, Niculescu M, Nielsen BS, Nikolaev S, Nikulin S, Nikulin V, Nilsen BS, Noferini F, Nomokonov P, Nooren G, Norman J, Nyanin A, Nystrand J, Oeschler H, Oh S, Oh SK, Okatan A, Olah L, Oleniacz J, Oliveira Da Silva AC, Onderwaater J, Oppedisano C, Ortiz Velasquez A, Oskarsson A, Otwinowski J, Oyama K, Ozdemir M, Sahoo P, Pachmayer Y, Pachr M, Pagano P, Paić G, Painke F, Pajares C, Pal SK, Palmeri A, Pant D, Papikyan V, Pappalardo GS, Pareek P, Park WJ, Parmar S, Passfeld A, Patalakha DI, Paticchio V, Paul B, Pawlak T, Peitzmann T, Pereira Da Costa H, Pereira De Oliveira Filho E, Peresunko D, Pérez Lara CE, Pesci A, Peskov V, Pestov Y, Petráček V, Petran M, Petris M, Petrovici M, Petta C, Piano S, Pikna M, Pillot P, Pinazza O, Pinsky L, Piyarathna DB, Płoskoń M, Planinic M, Pluta J, Pochybova S, Podesta-Lerma PLM, Poghosyan MG, Pohjoisaho EHO, Polichtchouk B, Poljak N, Pop A, Porteboeuf-Houssais S, Porter J, Potukuchi B, Prasad SK, Preghenella R, Prino F, Pruneau CA, Pshenichnov I, Puddu G, Pujahari P, Punin V, Putschke J, Qvigstad H, Rachevski A, Raha S, Rak J, Rakotozafindrabe A, Ramello L, Raniwala R, Raniwala S, Räsänen SS, Rascanu BT, Rathee D, Rauf AW, Razazi V, Read KF, Real JS, Redlich K, Reed RJ, Rehman A, Reichelt P, Reicher M, Reidt F, Renfordt R, Reolon AR, Reshetin A, Rettig F, Revol JP, Reygers K, Riabov V, Ricci RA, Richert T, Richter M, Riedler P, Riegler W, Riggi F, Rivetti A, Rocco E, Rodríguez Cahuantzi M, Rodriguez Manso A, Røed K, Rogochaya E, Rohni S, Rohr D, Röhrich D, Romita R, Ronchetti F, Ronflette L, Rosnet P, Rossi A, Roukoutakis F, Roy A, Roy C, Roy P, Rubio Montero AJ, Rui R, Russo R, Ryabinkin E, Ryabov Y, Rybicki A, Sadovsky S, Šafařík K, Sahlmuller B, Sahoo R, Sahu PK, Saini J, Sakai S, Salgado CA, Salzwedel J, Sambyal S, Samsonov V, Sanchez Castro X, Sánchez Rodríguez FJ, Šándor L, Sandoval A, Sano M, Santagati G, Sarkar D, Scapparone E, Scarlassara F, Scharenberg RP, Schiaua C, Schicker R, Schmidt C, Schmidt HR, Schuchmann S, Schukraft J, Schulc M, Schuster T, Schutz Y, Schwarz K, Schweda K, Scioli G, Scomparin E, Scott R, Segato G, Seger JE, Sekiguchi Y, Selyuzhenkov I, Seo J, Serradilla E, Sevcenco A, Shabetai A, Shabratova G, Shahoyan R, Shangaraev A, Sharma N, Sharma S, Shigaki K, Shtejer K, Sibiriak Y, Siddhanta S, Siemiarczuk T, Silvermyr D, Silvestre C, Simatovic G, Singaraju R, Singh R, Singha S, Singhal V, Sinha BC, Sinha T, Sitar B, Sitta M, Skaali TB, Skjerdal K, Slupecki M, Smirnov N, Snellings RJM, Søgaard C, Soltz R, Song J, Song M, Soramel F, Sorensen S, Spacek M, Spiriti E, Sputowska I, Spyropoulou-Stassinaki M, Srivastava BK, Stachel J, Stan I, Stefanek G, Steinpreis M, Stenlund E, Steyn G, Stiller JH, Stocco D, Stolpovskiy M, Strmen P, Suaide AAP, Sugitate T, Suire C, Suleymanov M, Sultanov R, Šumbera M, Susa T, Symons TJM, Szabo A, Szanto de Toledo A, Szarka I, Szczepankiewicz A, Szymanski M, Takahashi J, Tangaro MA, Tapia Takaki JD, Tarantola Peloni A, Tarazona Martinez A, Tarzila MG, Tauro A, Tejeda Muñoz G, Telesca A, Terrevoli C, Thäder J, Thomas D, Tieulent R, Timmins AR, Toia A, Trubnikov V, Trzaska WH, Tsuji T, Tumkin A, Turrisi R, Tveter TS, Ullaland K, Uras A, Usai GL, Vajzer M, Vala M, Valencia Palomo L, Vallero S, Vande Vyvre P, Van Der Maarel J, Van Hoorne JW, van Leeuwen M, Vargas A, Vargyas M, Varma R, Vasileiou M, Vasiliev A, Vechernin V, Veldhoen M, Velure A, Venaruzzo M, Vercellin E, Vergara Limón S, Vernet R, Verweij M, Vickovic L, Viesti G, Viinikainen J, Vilakazi Z, Villalobos Baillie O, Vinogradov A, Vinogradov L, Vinogradov Y, Virgili T, Viyogi YP, Vodopyanov A, Völkl MA, Voloshin K, Voloshin SA, Volpe G, von Haller B, Vorobyev I, Vranic D, Vrláková J, Vulpescu B, Vyushin A, Wagner B, Wagner J, Wagner V, Wang M, Wang Y, Watanabe D, Weber M, Wessels JP, Westerhoff U, Wiechula J, Wikne J, Wilde M, Wilk G, Wilkinson J, Williams MCS, Windelband B, Winn M, Yaldo CG, Yamaguchi Y, Yang H, Yang P, Yang S, Yano S, Yasnopolskiy S, Yi J, Yin Z, Yoo IK, Yushmanov I, Zaccolo V, Zach C, Zaman A, Zampolli C, Zaporozhets S, Zarochentsev A, Závada P, Zaviyalov N, Zbroszczyk H, Zgura IS, Zhalov M, Zhang H, Zhang X, Zhang Y, Zhao C, Zhigareva N, Zhou D, Zhou F, Zhou Y, Zhou Z, Zhu H, Zhu J, Zhu X, Zichichi A, Zimmermann A, Zimmermann MB, Zinovjev G, Zoccarato Y, Zyzak M. Exclusive J/ψ photoproduction off protons in ultraperipheral p-Pb collisions at √(s(NN))=5.02 TeV. PHYSICAL REVIEW LETTERS 2014; 113:232504. [PMID: 25526123 DOI: 10.1103/physrevlett.113.232504] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/01/2014] [Indexed: 06/04/2023]
Abstract
We present the first measurement at the LHC of exclusive J/ψ photoproduction off protons, in ultraperipheral proton-lead collisions at sqrt[s_{NN}]=5.02 TeV. Events are selected with a dimuon pair produced either in the rapidity interval, in the laboratory frame, 2.5<y<4 (p-Pb) or -3.6<y<-2.6 (Pb-p), and no other particles observed in the ALICE acceptance. The measured cross sections σ(γ+p→J/ψ+p) are 33.2±2.2(stat)±3.2(syst)±0.7(theor) nb in p-Pb and 284±36(stat)_{-32}^{+27}(syst)±26(theor) nb in Pb-p collisions. We measure this process up to about 700 GeV in the γp center of mass, which is a factor of two larger than the highest energy studied at HERA. The data are consistent with a power law dependence of the J/ψ photoproduction cross section in γp energies from about 20 to 700 GeV, or equivalently, from Bjorken x scaling variable between ∼2×10^{-2} and ∼2×10^{-5}, thus indicating no significant change in the gluon density behavior of the proton between HERA and LHC energies.
Collapse
|
|
11 |
15 |
169
|
Abelev B, Adam J, Adamová D, Aggarwal MM, Agnello M, Agostinelli A, Agrawal N, Ahammed Z, Ahmad N, Ahmad Masoodi A, Ahmed I, Ahn SU, Ahn SA, Aimo I, Aiola S, Ajaz M, Akindinov A, Aleksandrov D, Alessandro B, Alexandre D, Alici A, Alkin A, Alme J, Alt T, Altini V, Altinpinar S, Altsybeev I, Alves Garcia Prado C, Andrei C, Andronic A, Anguelov V, Anielski J, Antičić T, Antinori F, Antonioli P, Aphecetche L, Appelshäuser H, Arbor N, Arcelli S, Armesto N, Arnaldi R, Aronsson T, Arsene IC, Arslandok M, Augustinus A, Averbeck R, Awes TC, Azmi MD, Bach M, Badalà A, Baek YW, Bagnasco S, Bailhache R, Bala R, Baldisseri A, Baltasar Dos Santos Pedrosa F, Baral RC, Barbera R, Barile F, Barnaföldi GG, Barnby LS, Barret V, Bartke J, Basile M, Bastid N, Basu S, Bathen B, Batigne G, Batyunya B, Batzing PC, Baumann C, Bearden IG, Beck H, Bedda C, Behera NK, Belikov I, Bellini F, Bellwied R, Belmont-Moreno E, Bencedi G, Beole S, Berceanu I, Bercuci A, Berdnikov Y, Berenyi D, Bertens RA, Berzano D, Betev L, Bhasin A, Bhat IR, Bhati AK, Bhattacharjee B, Bhom J, Bianchi L, Bianchi N, Bianchin C, Bielčík J, Bielčíková J, Bilandzic A, Bjelogrlic S, Blanco F, Blau D, Blume C, Bock F, Bogdanov A, Bøggild H, Bogolyubsky M, Boldizsár L, Bombara M, Book J, Borel H, Borissov A, Bossú F, Botje M, Botta E, Böttger S, Braun-Munzinger P, Bregant M, Breitner T, Broker TA, Browning TA, Broz M, Bruna E, Bruno GE, Budnikov D, Buesching H, Bufalino S, Buncic P, Busch O, Buthelezi Z, Caffarri D, Cai X, Caines H, Caliva A, Calvo Villar E, Camerini P, Carena F, Carena W, Castillo Castellanos J, Casula EAR, Catanescu V, Cavicchioli C, Ceballos Sanchez C, Cepila J, Cerello P, Chang B, Chapeland S, Charvet JL, Chattopadhyay S, Chattopadhyay S, Chelnokov V, Cherney M, Cheshkov C, Cheynis B, Chibante Barroso V, Chinellato DD, Chochula P, Chojnacki M, Choudhury S, Christakoglou P, Christensen CH, Christiansen P, Chujo T, Chung SU, Cicalo C, Cifarelli L, Cindolo F, Cleymans J, Colamaria F, Colella D, Collu A, Colocci M, Conesa Balbastre G, Conesa del Valle Z, Connors ME, Contreras JG, Cormier TM, Corrales Morales Y, Cortese P, Cortés Maldonado I, Cosentino MR, Costa F, Crochet P, Cruz Albino R, Cuautle E, Cunqueiro L, Dainese A, Dang R, Danu A, Das D, Das I, Das K, Das S, Dash A, Dash S, De S, Delagrange H, Deloff A, Dénes E, D’Erasmo G, De Caro A, de Cataldo G, de Cuveland J, De Falco A, De Gruttola D, De Marco N, De Pasquale S, de Rooij R, Diaz Corchero MA, Dietel T, Divià R, Di Bari D, Di Liberto S, Di Mauro A, Di Nezza P, Djuvsland Ø, Dobrin A, Dobrowolski T, Domenicis Gimenez D, Dönigus B, Dordic O, Dubey AK, Dubla A, Ducroux L, Dupieux P, Dutta Majumdar AK, Ehlers RJ, Elia D, Engel H, Erazmus B, Erdal HA, Eschweiler D, Espagnon B, Esposito M, Estienne M, Esumi S, Evans D, Evdokimov S, Fabris D, Faivre J, Falchieri D, Fantoni A, Fasel M, Fehlker D, Feldkamp L, Felea D, Feliciello A, Feofilov G, Ferencei J, Fernández Téllez A, Ferreiro EG, Ferretti A, Festanti A, Figiel J, Figueredo MAS, Filchagin S, Finogeev D, Fionda FM, Fiore EM, Floratos E, Floris M, Foertsch S, Foka P, Fokin S, Fragiacomo E, Francescon A, Frankenfeld U, Fuchs U, Furget C, Fusco Girard M, Gaardhøje JJ, Gagliardi M, Gago AM, Gallio M, Gangadharan DR, Ganoti P, Garabatos C, Garcia-Solis E, Gargiulo C, Garishvili I, Gerhard J, Germain M, Gheata A, Gheata M, Ghidini B, Ghosh P, Ghosh SK, Gianotti P, Giubellino P, Gladysz-Dziadus E, Glässel P, Gomez Ramirez A, González-Zamora P, Gorbunov S, Görlich L, Gotovac S, Graczykowski LK, Grelli A, Grigoras A, Grigoras C, Grigoriev V, Grigoryan A, Grigoryan S, Grinyov B, Grion N, Grosse-Oetringhaus JF, Grossiord JY, Grosso R, Guber F, Guernane R, Guerzoni B, Guilbaud M, Gulbrandsen K, Gulkanyan H, Gunji T, Gupta A, Gupta R, Khan KH, Haake R, Haaland Ø, Hadjidakis C, Haiduc M, Hamagaki H, Hamar G, Hanratty LD, Hansen A, Harris JW, Hartmann H, Harton A, Hatzifotiadou D, Hayashi S, Heckel ST, Heide M, Helstrup H, Herghelegiu A, Herrera Corral G, Hess BA, Hetland KF, Hicks B, Hippolyte B, Hladky J, Hristov P, Huang M, Humanic TJ, Hutter D, Hwang DS, Ilkaev R, Ilkiv I, Inaba M, Innocenti GM, Ionita C, Ippolitov M, Irfan M, Ivanov M, Ivanov V, Ivanytskyi O, Jachołkowski A, Jacobs PM, Jahnke C, Jang HJ, Janik MA, Jayarathna PHSY, Jena S, Jimenez Bustamante RT, Jones PG, Jung H, Jusko A, Kadyshevskiy V, Kalcher S, Kalinak P, Kalweit A, Kamin J, Kang JH, Kaplin V, Kar S, Karasu Uysal A, Karavichev O, Karavicheva T, Karpechev E, Kebschull U, Keidel R, Khan MM, Khan P, Khan SA, Khanzadeev A, Kharlov Y, Kileng B, Kim B, Kim DW, Kim DJ, Kim JS, Kim M, Kim M, Kim S, Kim T, Kirsch S, Kisel I, Kiselev S, Kisiel A, Kiss G, Klay JL, Klein J, Klein-Bösing C, Kluge A, Knichel ML, Knospe AG, Kobdaj C, Köhler MK, Kollegger T, Kolojvari A, Kondratiev V, Kondratyeva N, Konevskikh A, Kovalenko V, Kowalski M, Kox S, Koyithatta Meethaleveedu G, Kral J, Králik I, Kramer F, Kravčáková A, Krelina M, Kretz M, Krivda M, Krizek F, Krus M, Kryshen E, Krzewicki M, Kučera V, Kucheriaev Y, Kugathasan T, Kuhn C, Kuijer PG, Kulakov I, Kumar J, Kurashvili P, Kurepin A, Kurepin AB, Kuryakin A, Kushpil S, Kweon MJ, Kwon Y, Ladron de Guevara P, Lagana Fernandes C, Lakomov I, Langoy R, Lara C, Lardeux A, Lattuca A, La Pointe SL, La Rocca P, Lea R, Lee GR, Legrand I, Lehnert J, Lemmon RC, Lenti V, Leogrande E, Leoncino M, León Monzón I, Lévai P, Li S, Lien J, Lietava R, Lindal S, Lindenstruth V, Lippmann C, Lisa MA, Ljunggren HM, Lodato DF, Loenne PI, Loggins VR, Loginov V, Lohner D, Loizides C, Lopez X, López Torres E, Lu XG, Luettig P, Lunardon M, Luo J, Luparello G, Luzzi C, Ma R, Maevskaya A, Mager M, Mahapatra DP, Maire A, Majka RD, Malaev M, Maldonado Cervantes I, Malinina L, Mal’Kevich D, Malzacher P, Mamonov A, Manceau L, Manko V, Manso F, Manzari V, Marchisone M, Mareš J, Margagliotti GV, Margotti A, Marín A, Markert C, Marquard M, Martashvili I, Martin NA, Martinengo P, Martínez MI, Martínez García G, Martin Blanco J, Martynov Y, Mas A, Masciocchi S, Masera M, Masoni A, Massacrier L, Mastroserio A, Matyja A, Mayer C, Mazer J, Mazzoni MA, Meddi F, Menchaca-Rocha A, Mercado Pérez J, Meres M, Miake Y, Mikhaylov K, Milano L, Milosevic J, Mischke A, Mishra AN, Miśkowiec D, Mitu CM, Mlynarz J, Mohanty B, Molnar L, Montaño Zetina L, Montes E, Morando M, Moreira De Godoy DA, Moretto S, Morreale A, Morsch A, Muccifora V, Mudnic E, Muhuri S, Mukherjee M, Müller H, Munhoz MG, Murray S, Musa L, Musinsky J, Nandi BK, Nania R, Nappi E, Nattrass C, Nayak TK, Nazarenko S, Nedosekin A, Nicassio M, Niculescu M, Nielsen BS, Nikolaev S, Nikulin S, Nikulin V, Nilsen BS, Noferini F, Nomokonov P, Nooren G, Nyanin A, Nystrand J, Oeschler H, Oh S, Oh SK, Okatan A, Olah L, Oleniacz J, Oliveira Da Silva AC, Onderwaater J, Oppedisano C, Ortiz Velasquez A, Oskarsson A, Otwinowski J, Oyama K, Sahoo P, Pachmayer Y, Pachr M, Pagano P, Paić G, Painke F, Pajares C, Pal SK, Palmeri A, Pant D, Papikyan V, Pappalardo GS, Pareek P, Park WJ, Parmar S, Passfeld A, Patalakha DI, Paticchio V, Paul B, Pawlak T, Peitzmann T, Pereira Da Costa H, Pereira De Oliveira Filho E, Peresunko D, Pérez Lara CE, Pesci A, Peskov V, Pestov Y, Petráček V, Petran M, Petris M, Petrovici M, Petta C, Piano S, Pikna M, Pillot P, Pinazza O, Pinsky L, Piyarathna DB, Płoskoń M, Planinic M, Pluta J, Pochybova S, Podesta-Lerma PLM, Poghosyan MG, Pohjoisaho EHO, Polichtchouk B, Poljak N, Pop A, Porteboeuf-Houssais S, Porter J, Pospisil V, Potukuchi B, Prasad SK, Preghenella R, Prino F, Pruneau CA, Pshenichnov I, Puddu G, Pujahari P, Punin V, Putschke J, Qvigstad H, Rachevski A, Raha S, Rak J, Rakotozafindrabe A, Ramello L, Raniwala R, Raniwala S, Räsänen SS, Rascanu BT, Rathee D, Rauf AW, Razazi V, Read KF, Real JS, Redlich K, Reed RJ, Rehman A, Reichelt P, Reicher M, Reidt F, Renfordt R, Reolon AR, Reshetin A, Rettig F, Revol JP, Reygers K, Ricci RA, Richert T, Richter M, Riedler P, Riegler W, Riggi F, Rivetti A, Rocco E, Rodríguez Cahuantzi M, Rodriguez Manso A, Røed K, Rogochaya E, Rohni S, Rohr D, Röhrich D, Romita R, Ronchetti F, Rosnet P, Rossegger S, Rossi A, Roukoutakis F, Roy A, Roy C, Roy P, Rubio Montero AJ, Rui R, Russo R, Ryabinkin E, Rybicki A, Sadovsky S, Šafařík K, Sahlmuller B, Sahoo R, Sahu PK, Saini J, Salgado CA, Salzwedel J, Sambyal S, Samsonov V, Sanchez Castro X, Sánchez Rodríguez FJ, Šándor L, Sandoval A, Sano M, Santagati G, Sarkar D, Scapparone E, Scarlassara F, Scharenberg RP, Schiaua C, Schicker R, Schmidt C, Schmidt HR, Schuchmann S, Schukraft J, Schulc M, Schuster T, Schutz Y, Schwarz K, Schweda K, Scioli G, Scomparin E, Scott R, Segato G, Seger JE, Sekiguchi Y, Selyuzhenkov I, Seo J, Serradilla E, Sevcenco A, Shabetai A, Shabratova G, Shahoyan R, Shangaraev A, Sharma N, Sharma S, Shigaki K, Shtejer K, Sibiriak Y, Siddhanta S, Siemiarczuk T, Silvermyr D, Silvestre C, Simatovic G, Singaraju R, Singh R, Singha S, Singhal V, Sinha BC, Sinha T, Sitar B, Sitta M, Skaali TB, Skjerdal K, Smakal R, Smirnov N, Snellings RJM, Søgaard C, Soltz R, Song J, Song M, Soramel F, Sorensen S, Spacek M, Sputowska I, Spyropoulou-Stassinaki M, Srivastava BK, Stachel J, Stan I, Stefanek G, Steinpreis M, Stenlund E, Steyn G, Stiller JH, Stocco D, Stolpovskiy M, Strmen P, Suaide AAP, Sugitate T, Suire C, Suleymanov M, Sultanov R, Šumbera M, Susa T, Symons TJM, Szanto de Toledo A, Szarka I, Szczepankiewicz A, Szymanski M, Takahashi J, Tangaro MA, Tapia Takaki JD, Tarantola Peloni A, Tarazona Martinez A, Tauro A, Tejeda Muñoz G, Telesca A, Terrevoli C, Thäder J, Thomas D, Tieulent R, Timmins AR, Toia A, Torii H, Trubnikov V, Trzaska WH, Tsuji T, Tumkin A, Turrisi R, Tveter TS, Ulery J, Ullaland K, Uras A, Usai GL, Vajzer M, Vala M, Valencia Palomo L, Vallero S, Vande Vyvre P, Vannucci L, Van Hoorne JW, van Leeuwen M, Vargas A, Varma R, Vasileiou M, Vasiliev A, Vechernin V, Veldhoen M, Velure A, Venaruzzo M, Vercellin E, Vergara Limón S, Vernet R, Verweij M, Vickovic L, Viesti G, Viinikainen J, Vilakazi Z, Villalobos Baillie O, Vinogradov A, Vinogradov L, Vinogradov Y, Virgili T, Viyogi YP, Vodopyanov A, Völkl MA, Voloshin K, Voloshin SA, Volpe G, von Haller B, Vorobyev I, Vranic D, Vrláková J, Vulpescu B, Vyushin A, Wagner B, Wagner J, Wagner V, Wang M, Wang Y, Watanabe D, Weber M, Wessels JP, Westerhoff U, Wiechula J, Wikne J, Wilde M, Wilk G, Wilkinson J, Williams MCS, Windelband B, Winn M, Xiang C, Yaldo CG, Yamaguchi Y, Yang H, Yang P, Yang S, Yano S, Yasnopolskiy S, Yi J, Yin Z, Yoo IK, Yushmanov I, Zaccolo V, Zach C, Zaman A, Zampolli C, Zaporozhets S, Zarochentsev A, Závada P, Zaviyalov N, Zbroszczyk H, Zgura IS, Zhalov M, Zhang H, Zhang X, Zhang Y, Zhao C, Zhigareva N, Zhou D, Zhou F, Zhou Y, Zhu H, Zhu J, Zhu X, Zichichi A, Zimmermann A, Zimmermann MB, Zinovjev G, Zoccarato Y, Zynovyev M, Zyzak M. Measurement of quarkonium production at forward rapidity in [Formula: see text] collisions at [Formula: see text]TeV. THE EUROPEAN PHYSICAL JOURNAL. C, PARTICLES AND FIELDS 2014; 74:2974. [PMID: 25814905 PMCID: PMC4370879 DOI: 10.1140/epjc/s10052-014-2974-4] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/10/2014] [Accepted: 07/09/2014] [Indexed: 06/04/2023]
Abstract
The inclusive production cross sections at forward rapidity of [Formula: see text], [Formula: see text], [Formula: see text](1S) and [Formula: see text](2S) are measured in [Formula: see text] collisions at [Formula: see text] with the ALICE detector at the LHC. The analysis is based on a data sample corresponding to an integrated luminosity of 1.35 pb[Formula: see text]. Quarkonia are reconstructed in the dimuon-decay channel and the signal yields are evaluated by fitting the [Formula: see text] invariant mass distributions. The differential production cross sections are measured as a function of the transverse momentum [Formula: see text] and rapidity [Formula: see text], over the ranges [Formula: see text] GeV/c for [Formula: see text], [Formula: see text] GeV/c for all other resonances and for [Formula: see text]. The measured cross sections integrated over [Formula: see text] and [Formula: see text], and assuming unpolarized quarkonia, are: [Formula: see text] [Formula: see text]b, [Formula: see text] [Formula: see text]b, [Formula: see text] nb and [Formula: see text] nb, where the first uncertainty is statistical and the second one is systematic. The results are compared to measurements performed by other LHC experiments and to theoretical models.
Collapse
|
research-article |
11 |
15 |
170
|
|
review-article |
25 |
15 |
171
|
Murray S, Linardou H, Mountzios G, Manoloukos M, Markaki S, Eleutherakis-Papaiakovou E, Dimopoulos MA, Papadimitriou CA. Low frequency of somatic mutations in uterine sarcomas: a molecular analysis and review of the literature. Mutat Res 2010; 686:68-73. [PMID: 20122944 DOI: 10.1016/j.mrfmmm.2010.01.019] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2009] [Revised: 01/21/2010] [Accepted: 01/25/2010] [Indexed: 05/28/2023]
Abstract
OBJECTIVE The rarity of uterine sarcomas along with their pathological and molecular heterogeneities render their study particularly challenging. We evaluated a panel of somatic mutations principally centering on the tyrosine kinase gene family and their downstream signaling cascades in an attempt to identify potential candidate markers that may assist in diagnostic or therapeutic decisions in these tumors. METHODS We performed mutational analysis of 20 exons from 9 genes (EGFR, CDKN2A, MET, KIT, RAS, BRAF, PI3KCA, HER-2 and PDGFR-alpha) on biopsy material from 25 patients who underwent primary surgery for uterine sarcoma between October 1995 and October 2003. Due to the limited number of studies conducted we have also undertaken a literature review of somatic mutations in uterine sarcomas. RESULTS A total of 3 different somatic mutations were identified: one KRAS (codon G12D) in a carcinosarcoma and two exon 20 PI3KCA mutations (H1047R and H1047Y) both in carcinosarcomas. Mutational status of all mutations was confirmed using germline DNA extracted from peripheral blood. Consistent with the literature data, no other mutations regarding the rest of the genes of the panel were identified. Due to the low number of somatic mutations in our series, we did not perform further clinicopathological correlations. CONCLUSION The absence of somatic mutations in the majority of genes that are considered critical in neoplastic transformation hampers the identification of potential therapeutic targets in patients with uterine sarcoma.
Collapse
|
Review |
15 |
15 |
172
|
Exley C, Schley L, Murray S, Hackney CM, Birchall JD. Aluminium, beta-amyloid and non-enzymatic glycosylation. FEBS Lett 1995; 364:182-4. [PMID: 7750567 DOI: 10.1016/0014-5793(95)00388-p] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
The non-enzymatic glycosylation of beta-amyloid is implicated in the aetiology of Alzheimer's disease. However, controversy surrounds the nature of any involvement and a potential mechanism has not been fully elucidated. We present evidence of an aluminium-induced aggregation of the A beta P(25-35) peptide and speculate that the mechanism of formation of our ordered beta-amyloid aggregates might involve non-enzymatic glycosylation and/or site-specific crosslinking of beta-amyloid fibrils by atomic aluminium.
Collapse
|
|
30 |
14 |
173
|
Allport JR, Donnelly LE, Kefalas P, Lo G, Nunn A, Yadollahi-Farsani M, Rendell NB, Murray S, Taylor GW, MacDermot J. A possible role for mono (ADP-ribosyl) transferase in the signalling pathway mediating neutrophil chemotaxis. Br J Clin Pharmacol 1996; 42:99-106. [PMID: 8807150 PMCID: PMC2042641 DOI: 10.1046/j.1365-2125.1996.37014.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
1. Mono(ADP-ribosyl)transferase activity has been identified on the external surface of human polymorphonuclear neutrophil leucocytes (PMNs). The enzyme is released from the plasma membrane by phosphoinositide-specific phospholipase C, suggesting a glycosylphosphatidylinositol (GPI) linkage of the enzyme to the plasma membrane. Partial sequence of cDNA encoding the enzyme suggests that it is identical to the GPI-linked mono(ADP-ribosyl)-transferase identified previously on human skeletal muscle. 2. A panel of inhibitors of mono(ADP-ribosyl)transferase (including vitamins K1 and K3, novobiocin and nicotinamide) showed a rank order of inhibitory potency similar to that described for other mono(ADP-ribosyl)transferases. Furthermore, the mono(ADP-ribosyl)ation of agmatine was inhibited also by diethylamino (benzylidineamino)guanidine (DEA-BAG), another substrate of the enzyme related structurally to arginine. 3. There was a close linear correlation between the IC50 values for inhibition of mono(ADP-ribosyl)ation of agmatine by DEA-BAG or the enzyme inhibitors and their IC50 values for inhibition of receptor-dependent polymerization of cytoskeletal actin and chemotaxis. 4. These results suggest a role for mono(ADP-ribosyl)transferase in the transduction pathway involved in receptor-dependent re-alignment of the cytoskeleton during neutrophil chemotaxis.
Collapse
|
research-article |
29 |
14 |
174
|
Murray S. Nonparametric rank-based methods for group sequential monitoring of paired censored survival data. Biometrics 2000; 56:984-90. [PMID: 11129495 DOI: 10.1111/j.0006-341x.2000.0984.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
This research gives methods for nonparametric sequential monitoring of paired censored survival data in the two-sample problem using paired weighted log-rank statistics with adjustments for dependence in survival and censoring outcomes. The joint asymptotic closed-form distribution of these sequentially monitored statistics has a dependent increments structure. Simulations validating operating characteristics of the proposed methods highlight power and size consequences of ignoring even mildly correlated data. A motivating example is presented via the Early Treatment Diabetic Retinopathy Study.
Collapse
|
|
25 |
14 |
175
|
Murray S, Trudeau M, Antonelli DM. X-ray photoelectron spectroscopy and magnetic studies on the effect of pore size, wall thickness, and wall composition on superparamagnetic cobaltocene mesoporous Nb, Ta, and Ti composites. Inorg Chem 2000; 39:5901-8. [PMID: 11151490 DOI: 10.1021/ic000678f] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Recent results in our group demonstrated that mixed oxidation state mesoporous niobium oxide cobaltocene composites display superparamagnetism at certain composition ratios. This was the first report of superparamagnetism in nanoscale molecular ensembles. A series of mesoporous niobium oxide materials were synthesized in order to understand the role of pore size and thickness of the walls in the mesostructure on the magnetic properties. Mesoporous Ti oxide and Ta oxide composites were also synthesized in order to investigate the effect of changing the wall composition on the magnetic properties of this new series of materials. All samples were characterized by X-ray diffraction, nitrogen adsorption, ultraviolet spectroscopy, X-ray photoelectron spectroscopy, scanning electron microscopy, and superconducting quantum interference device magnetometry. The results of this study showed that variation of wall thickness or pore size in the Nb system had little effect on the properties and that superparamagnetism most likely arises from mixed oxidation state cobaltocene grains residing in the individual pores and not from the free electrons in the mesostructure or much larger domains. The Langevin function was applied to the isothermal magnetic data from the Nb composites and gave mean superparamagnetic particle sizes of ca. 14 nm in each system. The Co(II) to Co(III) ratios in these materials were approximately 1:1. The Ti and Ta materials showed no sign of superparamagnetism and only very low levels of neutral cobaltocene in the pores. This suggests that a critical amount of cobaltocene is required to bring about superparamagnetic behavior.
Collapse
|
|
25 |
14 |